17.73
price up icon2.01%   0.35
after-market Dopo l'orario di chiusura: 17.73
loading
Precedente Chiudi:
$17.38
Aprire:
$17.37
Volume 24 ore:
976.91K
Relative Volume:
0.86
Capitalizzazione di mercato:
$972.79M
Reddito:
$14.34M
Utile/perdita netta:
$-199.00M
Rapporto P/E:
-4.523
EPS:
-3.92
Flusso di cassa netto:
$-183.51M
1 W Prestazione:
+9.04%
1M Prestazione:
+28.76%
6M Prestazione:
+56.49%
1 anno Prestazione:
+227.73%
Intervallo 1D:
Value
$16.56
$17.79
Intervallo di 1 settimana:
Value
$15.59
$17.79
Portata 52W:
Value
$4.45
$19.18

Uniqure N V Stock (QURE) Company Profile

Name
Nome
Uniqure N V
Name
Telefono
1-339-970-7000
Name
Indirizzo
PAASHEUVELWEG 25A, AMSTERDAM
Name
Dipendente
209
Name
Cinguettio
@uniQure_NV
Name
Prossima data di guadagno
2024-07-30
Name
Ultimi documenti SEC
Name
QURE's Discussions on Twitter

Confronta QURE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
QURE
Uniqure N V
17.73 933.29M 14.34M -199.00M -183.51M -3.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Uniqure N V Stock (QURE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-08-14 Aggiornamento Mizuho Neutral → Outperform
2025-04-01 Ripresa Chardan Capital Markets Buy
2024-12-10 Aggiornamento Raymond James Outperform → Strong Buy
2024-10-10 Ripresa Raymond James Outperform
2024-02-29 Downgrade Goldman Buy → Neutral
2023-12-19 Downgrade Mizuho Buy → Neutral
2022-03-17 Aggiornamento UBS Neutral → Buy
2021-06-15 Iniziato BTIG Research Buy
2021-05-21 Iniziato UBS Neutral
2021-04-26 Ripresa Credit Suisse Outperform
2021-04-01 Aggiornamento Mizuho Neutral → Buy
2021-01-07 Aggiornamento Guggenheim Neutral → Buy
2020-11-24 Iniziato H.C. Wainwright Buy
2020-11-11 Iniziato Berenberg Buy
2020-11-09 Iniziato Jefferies Buy
2020-11-04 Iniziato Cantor Fitzgerald Overweight
2020-10-23 Iniziato RBC Capital Mkts Outperform
2020-08-25 Iniziato Raymond James Strong Buy
2020-07-31 Aggiornamento Robert W. Baird Neutral → Outperform
2020-06-25 Downgrade Mizuho Buy → Neutral
2020-06-25 Downgrade Robert W. Baird Outperform → Neutral
2020-06-25 Downgrade Wells Fargo Overweight → Equal Weight
2019-12-03 Iniziato Cowen Outperform
2019-12-03 Iniziato Goldman Buy
2019-11-05 Iniziato Credit Suisse Outperform
2019-10-11 Iniziato Stifel Buy
2019-09-25 Iniziato Bernstein Outperform
2019-09-12 Iniziato Mizuho Buy
2019-07-30 Downgrade Guggenheim Buy → Neutral
2019-07-08 Reiterato Cantor Fitzgerald Overweight
2019-04-12 Iniziato Piper Jaffray Overweight
2019-03-29 Iniziato Robert W. Baird Outperform
Mostra tutto

Uniqure N V Borsa (QURE) Ultime notizie

pulisher
Sep 03, 2025

Understanding uniQure N.V.’s price movementCEO Change & Weekly Momentum Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Has uniQure N.V. formed a bullish divergence2025 Key Lessons & Fast Gain Stock Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What does recent volatility data suggest for uniQure N.V.Trade Entry Summary & Community Verified Watchlist Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What indicators show strength in uniQure N.V.2025 Technical Patterns & Safe Capital Preservation Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ranking uniQure N.V. among high performing stocks via tools2025 Key Lessons & Consistent Growth Equity Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Long term hold vs stop loss in uniQure N.V.Market Performance Report & Verified Short-Term Trading Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Price action breakdown for uniQure N.V.2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can uniQure N.V. rally from current levelsJuly 2025 Price Swings & Accurate Buy Signal Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using economic indicators to assess uniQure N.V. potential2025 Historical Comparison & Smart Investment Allocation Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is now a turning point for uniQure N.V.Weekly Risk Report & Free Risk Controlled Daily Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can uniQure N.V. outperform in the next rallyJuly 2025 Update & Long-Term Safe Investment Ideas - khodrobank.com

Sep 03, 2025
pulisher
Sep 02, 2025

uniQure N.V. stock chart pattern explained2025 Price Momentum & Consistent Growth Stock Picks - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Using data tools to time your uniQure N.V. exitPortfolio Profit Report & Weekly Stock Performance Updates - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Chart based analysis of uniQure N.V. trendsProduct Launch & AI Powered Market Entry Ideas - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

What technical models suggest about uniQure N.V.’s comebackRate Cut & Community Trade Idea Sharing - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Comparing uniQure N.V. in custom built stock radarsAnalyst Downgrade & Long-Term Safe Investment Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Published on: 2025-09-01 20:24:08 - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Technical analysis overview for uniQure N.V. stockPortfolio Return Report & Precise Trade Entry Recommendations - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

What’s the outlook for uniQure N.V.’s sectorJuly 2025 Momentum & Verified Stock Trade Ideas - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Can uniQure N.V. hit a new high this month2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Building trade automation scripts for uniQure N.V.2025 Price Action Summary & Long-Term Growth Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Growth Value: Does uniQure N.V. have pricing power2025 Momentum Check & Short-Term Swing Trade Alerts - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Should you hold or exit uniQure N.V. nowWeekly Investment Summary & Accurate Buy Signal Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Institutional investors are uniQure N.V.'s (NASDAQ:QURE) biggest bettors and were rewarded after last week's US$53m market cap gain - simplywall.st

Sep 01, 2025
pulisher
Sep 01, 2025

Using data filters to optimize entry into uniQure N.V.Analyst Downgrade & Entry and Exit Point Strategies - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

uniQure N.V. stock trend outlook and recovery path2025 Price Targets & Smart Swing Trading Techniques - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Tick level data insight on uniQure N.V. volatilityMarket Activity Report & Smart Swing Trading Techniques - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will a bounce in uniQure N.V. offer an exitTreasury Yields & Advanced Swing Trade Entry Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How to escape a deep drawdown in uniQure N.V.Market Growth Report & Free Long-Term Investment Growth Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Should you wait for a breakout in uniQure N.V.Weekly Profit Report & AI Based Buy and Sell Signals - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Relative strength of uniQure N.V. in sector analysisWall Street Watch & Long-Term Investment Growth Plans - Newser

Aug 30, 2025

Uniqure N V Azioni (QURE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Uniqure N V Azioni (QURE) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Springhorn Jeremy P.
Director
Jun 20 '25
Sale
14.45
2,112
30,518
37,694
POST LEONARD E
Director
Jun 20 '25
Sale
14.45
2,112
30,518
29,937
Kaye Jack
Director
Jun 20 '25
Sale
14.45
2,112
30,518
20,439
Jacques Rachelle Suzanne
Director
Jun 20 '25
Sale
14.45
2,112
30,518
28,346
Gut Robert
Director
Jun 20 '25
Sale
14.45
3,336
48,205
56,879
Balachandran Madhavan
Director
Jun 20 '25
Sale
14.45
2,112
30,518
37,697
Meek David D.
Director
Jun 20 '25
Sale
14.45
2,112
30,518
34,190
Potts Jeannette
Chief Legal Officer
Jun 16 '25
Sale
15.14
4,670
70,704
115,073
Kapusta Matthew C
CEO, Managing Director
Mar 04 '25
Sale
10.29
28,341
291,629
651,454
Abi-Saab Walid
Chief Medical Officer
Mar 04 '25
Sale
10.29
1,350
13,891
151,903
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):